Contraline Appoints Medical Device Industry Leader Dr. Yelena Tropsha as Chief Technology Officer

• Health care gadget merchandise growth and commercialization specialist of 25 yrs, Yelena Tropsha, PhD, joins Contraline as Chief Engineering Officer

• Dr. Tropsha will spearhead initiatives to bring Contraline’s male contraceptive system, ADAM™, toward Fda approval

CHARLOTTESVILLE, Va., March 30, 2022–(Business WIRE)–Contraline, Inc., a venture-backed health-related device corporation devoted to offering guys with extended-lasting, secure, and productive contraception has appointed health-related device sector chief Dr. Yelena Tropsha to the position of Main Technological know-how Officer.

This push launch options multimedia. Perspective the total release right here: https://www.businesswire.com/news/household/20220330005043/en/

Dr. Yelena Tropsha joins Contraline as Main Know-how Officer (Image: Organization Wire)

Dr. Tropsha brings to Contraline above 25 decades of health care unit encounter, from front-stop innovation to commercialization. Dr. Tropsha served for 10 several years with Coloplast as Vice President of Implantable Equipment, Urology where she was dependable for R&D, Medical, Medical and Regulatory Affairs. Dr. Tropsha also held Vice Presidential positions with major medical product businesses DYSIS Professional medical and Neuronetics and senior complex positions at Medtronic and Becton Dickinson.

Over the study course of her profession, Dr. Tropsha has been involved in the advancement, approvals, and launches of 19 Course II and Course III medical gadgets in urology and gynecology. In addition to professional medical gadget growth, her skills is in resources science with emphasis on polymers and biomaterials. She is outlined as an inventor on about 25 patents and 20 publications.

“Yelena joins our team at an enjoyable time forward of our initially-in-human scientific demo of ADAM™, the world’s first injectable hydrogel built to supply extended-long lasting, non-long lasting vas-occlusion for males,” claimed Kevin Eisenfrats, Co-Founder and Chief Government Officer of Contraline.

“We are charting the route to convey a revolutionary reproductive professional medical machine like ADAM™ to market. We are also beginning to extend the probable uses for our hydrogel platform. We will enormously reward from Yelena’s encounter foremost several organizations with innovative clinical gadgets in urology and gynecology to profitable regulatory and business results.”

Tale continues

At Contraline, Dr. Tropsha will spearhead R&D, regulatory affairs, and industry obtain. She will also guide attempts to extend use of Contraline’s proprietary hydrogel platform for new indications in reproductive overall health past vas-occlusion.

“I am thrilled and honored to be portion of Contraline’s crew, representing a new period in contraceptive technologies. Contraline’s do the job to develop a hydrogel for vas-occlusion draws from my regions of desire and skills: health-related gadget growth, urology, and polymer science. The possibility to travel the ADAM™ item from preclinical research via commercialization will be a job emphasize for me,” mentioned Yelena Tropsha.

Dr. Tropsha holds a master’s diploma in Chemistry and a PhD in Polymer Science from Moscow Condition University in Russia.

About Contraline

Contraline, Inc. is a venture-backed clinical system firm devoted to providing men and partners with prolonged-lasting, safe and sound, and efficient contraception. The organization is creating ADAM™, the world’s 1st injectable hydrogel created to present very long-lasting barrier contraception for guys. The corporation was started in 2015 by Kevin Eisenfrats and Dr. John Herr, and is headquartered in Charlottesville, Virginia. To understand far more, visit http://www.contraline.com

Check out supply edition on businesswire.com: https://www.businesswire.com/news/home/20220330005043/en/

Contacts

Kevin Eisenfrats
[email protected]